PHATPhathom Pharmaceuticals, Inc.
$7.12-34% 1Y
$7.12
$6.7252 weeks$18.08
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−37% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 8, 2026
In a downtrend, below its 50- and 200-day averages. Price is −37% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PHAT is trading
Phathom Pharmaceuticals, Inc. is −34% over the past year while the S&P 500 is +18%: 53 points behind the market.
−34%
1-year return · S&P 500 +18%
- vs 200-day average
- −37%
vs 200-day average · a clear downtrend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- 61%
Below its 52-week high
Details›
- Last close2026-10-08
- $7.12
- 1 monthS&P 500 +1.6%
- −18%
- 1 yearS&P 500 +18%
- −34%
- 5 yearsS&P 500 +86%
- −78%
- vs 50-day average$8.33
- −15%
- 52-week high
- $18.08
- 52-week low
- $6.72
- Annualised volatility
- 106%
| Year | Return |
|---|---|
| 2026 (year to date) | −57% |
| 2025 | +104% |
| 2024 | −11% |
| 2023 | −19% |
| 2022 | −43% |
| 2021 | −41% |
| 2020 | +6.7% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 3 of 7 | −8.0% |
| Feb | 7 | 4 of 7 | +6.6% |
| Mar | 7 | 1 of 7 | −12% |
| Apr | 7 | 4 of 7 | +4.7% |
| May | 7 | 3 of 7 | −4.1% |
| Jun | 7 | 5 of 7 | +23% |
| Jul | 7 | 4 of 7 | −0.43% |
| Aug | 7 | 5 of 7 | +14% |
| Sep | 7 | 2 of 7 | −3.7% |
| Oct | 7 | 2 of 7 | −3.8% |
| Nov | 7 | 3 of 7 | −10% |
| Dec | 7 | 5 of 7 | +7.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.